Feasibility of blood self-sampling with HemaSpot HF for Anti-Clostridium tetani Toxin IgG detection
Kettlitz et al.
The finding, in our words
Among 154 volunteers, 85% found HemaSpot HF self-sampling acceptable, but correlation with venous blood for anti-tetanus toxin IgG was moderate (r = 0.73) and sensitivity varied from 70% to 100% depending on the cut-off value, with concentration differences widening at higher IgG levels. The device requires further improvement before it can reliably replace venous puncture for decentralised serological testing.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
The study found that DBS testing showed high specificity for HIV, HBV and HCV and perfect sensitivity for HIV and HBV, but lower sensitivity for syphilis and HCV, with creatinine measurements slightly higher than venous samples. Despite challenges in sample adequacy, DBS was acceptable to participants and could support decentralised STI and renal monitoring in men who have sex with men.
Nieuwenburg et al., Sexually transmitted diseases · source ↗
In a Ugandan cohort, 96% of participants successfully collected at least 16 of 24 requested at-home dried blood spots, with strong correlation (R=0.93) between parasite RNA detected in self-collected spots and venous blood. The method was well tolerated, indicating self-collected DBS can reliably support decentralised malaria surveillance in endemic settings.
The study found that although participants preferred patient-centric microsampling devices for home use, the agreement with venous plasma for measuring CRP and cytokines was inconsistent, indicating that further validation is required before these methods replace standard venipuncture.
The study validated a semi-quantitative protocol for Epstein-Barr virus serology using dried blood spots, demonstrating 98.8% sensitivity and 96.5% specificity compared to paired venous serum samples. The successful validation in a self-sampling cohort confirms the suitability of this patient-centric microsampling approach for large-scale seroprevalence studies and decentralised trials.
In a pilot mixed-methods study of youth with HIV, mailed HemaSpot-HF kits enabled home-based dried blood spot collection that participants found feasible and acceptable, supporting remote viral load monitoring and a self-management model for decentralised care.
Gurung et al., AIDS and behavior (paywalled) · source ↗